InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.19
(
0.07%
)
Bitcoin
64,153.41
(
0.24%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioHunter

Send PM Follow Ignore
Followers 246
Posts 636
Boards Moderated 1
Alias Born 04/20/2007

BioHunter

Re: None

Wednesday, 07/27/2016 8:01:39 AM

Wednesday, July 27, 2016 8:01:39 AM

Post# of 97237
$KPTI

Middle of press release company announced ODD Orphan Drug designation by FDA

"Today, Karyopharm also announced that selinexor has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of soft tissue sarcoma (STS)."


Press release shows selinexor is active, in upcoming STORM trial looking for 20% ORR. Data for STORM should be mid to late August.

BioHunter

-BioHunter
Twitter: @TheBio_Hunter

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up